Specific Substances: 1,2,3,4-Tetrahydro-9-acridinamine
Nomination Date: 09/21/1987
Rationale: Tetrajudrpa,ompacrodome (THA) is an anticholinesterase agent which is currently being tested in a clinical trial for its efficacy in the treatment of Alzheimer's disease. No data on the chronic toxicity of THA in animals or humans.
NTP Principles: not specified
Status: No Testing
Agents and Status
The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.
Agent Name: 1,2,3,4-Tetrahydro-9-acridinamine